详情
V-maf Musculoaponeurotic Fibrosarcoma Oncogene F Human Recombinant
目录号 | AP0782 |
---|---|
Physical Appearance | Sterile Filtered colorless solution. |
Formulation | The MAFF solution (1mg/ml) contains 20mM Tris-HCl buffer (pH8.0), 10% glycerol and 0.4M Urea. |
Amino acid sequence | MGSSHHHHHH SSGLVPRGSH MGSMSVDPLS SKALKIKREL SENTPHLSDE ALMGLSVREL NRHLRGLSAE EVTRLKQRRR TLKNRGYAAS CRVKRVCQKE ELQKQKSELE REVDKLAREN AAMRLELDAL RGKCEALQGF ARSVAAARGP ATLVAPASVI TIVKSTPGSG SGPAHGPDPA HGPASCS. |
Uniprot ACC# | Q9ULX9 |
Purity | Greater than 85% as determined by SDS-PAGE. |
Stability | Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles. |
Source | E.coli. |
Synonyms | hMafF, U-MAF, Transcription factor MafF, U-Maf, V-maf musculoaponeurotic fibrosarcoma oncogene homolog F, MAFF. |
Transportation method | Shipped with Ice Packs |
产品资料
产品标签
Product Questions
Product Questions
No Questions